Stevard, LLC
- SEC CIK
- 0001812093
- Latest filing
- Feb 13, 2025
CRSP holding history
CRISPR Therapeutics AG in every 13F filed by Stevard, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRSP overviewAll 13F holders of CRSPFull Q4 2024 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −5,011−100.0% | Sold out | Holders |
| Q2 2024 | 5,011 | $270.6K | 0.2% | −396−7.3% | Reduced | Holders |
| Q1 2024 | 5,407 | $368.5K | 0.3% | +121+2.3% | Added | Holders |
| Q4 2023 | 5,286 | $330.9K | 0.3% | +5,286 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −4,356−100.0% | Sold out | Holders |
| Q2 2023 | 4,356 | $244.5K | 0.2% | −1,362−23.8% | Reduced | Holders |
| Q1 2023 | 5,718 | $258.6K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2022 | 5,718 | $232.4K | 0.2% | 00.0% | Unchanged | Holders |
| Q3 2022 | 5,718 | $374.0K | 0.4% | – | No prior filing | Holders |
| Q2 2022 | – | – | – | – | Not filed | Holders |
| Q1 2022 | 5,718 | $359.0K | 0.3% | −969−14.5% | Reduced | Holders |
| Q4 2021 | 6,687 | $507.0K | 0.4% | −1,350−16.8% | Reduced | Holders |
| Q3 2021 | 8,037 | $900.0K | 0.7% | +94+1.2% | Added | Holders |
| Q2 2021 | 7,943 | $1.29M | 1.0% | +42+0.5% | Added | Holders |
| Q1 2021 | 7,901 | $963.0K | 0.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.